phrma

18 Aug: About that $80 billion Big Pharma promised for healthcare reform

The pharmaceutical industry, through its lobbying group PhRMA, has promised to cut drug prices for certain Medicare Part D recipients and others by $80 billion over the next decade. In return, the Obama Administration has promised not to reform the pharmaceutical industry — no new regulations, no Medicare negotiation for lower drug prices, no drug reimportation from Canada. Sound like a good deal to you? Well, $80 billion sure sounds like a lot of money. But here are some things to think about — President Obama trumpeted the deal without indicating how or whether these savings could be guaranteed; the specific terms are not included in any of the bills in Congress. Some analysts estimate that only $30 billion of…

20 Jul: Invasion of the body snatchers: Harry and Louise return

Did you ever see “Invasion of the Body Snatchers”? Well, I’d like to report the snatching of two bodies — those of Harry and Louise. As our friend John Mack reports: Remember those Health Insurance Association of America “Harry and Louise” TV ads that were instrumental in scuttling Hillary Clinton’s health reform efforts in 1993? Well, Harry and Louise are back! This time, however, they support health reform. “A little more cooperation, a little less politics, and we can get the job done this time,” says Louise as a halo swirls around her head and eventually forms the URL: HarryandLouise.org. Seems to me we could have gotten the job done in 1993 with a little less Harry and Louise! Here’s…

23 Jan: Even PhRMA can’t spin this

From O’Dwyer’s PR Blog: The Vytorin controversy is just icing on a (low cholesterol) cake for those upset with the barrage of drug advertising, and the promotion of “quasi diseases” by big pharmaceutical houses. It’s a safe bet the Congress is going to step up efforts to regulate the marketing practices of prescription drugs. Bart Stupak, chair of the Energy and Commerce investigations subcommittee told the WSJ that is sick and tired on seeing “puffing, advertising based on untrue facts or facts that can’t be substantiated, medical, ethically or legally.” Ouch. Even the Rx industry’s trade group, Pharmaceutical Research and Manufacturers of America, is raising the white flag. Chief Billy Tauzin admits that some of the criticism of the industry…